Group wants heart attack warning on testosterone
Feb 25, 2014
By MATTHEW PERRONE
AP Health Writer
WASHINGTON (AP) -- A consumer advocacy group is calling on the Food and Drug Administration to add a bold warning label to popular testosterone drugs for men in light of growing evidence that the hormone treatments can increase the risk of heart attack.
The group Public Citizen says the agency should immediately add a "black box" warning - the most serious type - to all testosterone medications and require manufacturers to warn physicians about a higher risk of heart attack, stroke and death with the treatments.
The FDA announced last month that it was reviewing the safety of drugs like the blockbuster testosterone gel, AndroGel, in light of two recent studies that showed higher rates of cardiovascular problems in men. The agency said its review was first prompted by a U.S. Veterans Affairs study published in November 2013 that showed a 30 percent increase in stroke, heart attack and death among older men taking testosterone.
[Article continues at original source]